On 12 June, ANSES and the ANSM signed a new framework agreement to reinforce their partnership across the entire field of human and veterinary medicinal products. This new agreement between the two health agencies also provides for cooperation to be extended to all possible synergies according to the "One Health" approach.

Over the last few months, ANSES and Santé publique France have been actively finalising the launch of Albane. This major national survey will collect data on health, chemical exposure, food consumption and physical activity over two-year cycles, based on representative samples drawn from the population, from birth to 79 years of age. Funded by the Ministries of Health, the Environment, Agriculture and Labour, Albane will support both agencies’ missions and generate useful indicators for monitoring the effectiveness of public policies in the fields investigated.

Matthieu Schuler Managing Director General of the Science for Expertise Division about the phytopharmacovigilance : "With this phytopharmacovigilance scheme, we have taken a real step forward in capturing data on plant protection products as used and their residues in the environment."

With the renewal of its Scientific Board in April 2023, ANSES wanted to give it an international dimension by bringing together scientists, researchers and experts from France and other countries. The Agency’s Scientific Board functions as an independent body, to guarantee the excellence of its expert appraisals and the consistency of its scientific work. Human food and nutrition, environmental health, occupational health, animal health and welfare, animal nutrition, veterinary medicinal products, plant health and protection: the Board’s work covers all of the Agency’s missions, while respecting the pluralism and independence of its expert appraisals. On 7 December 2023, Marta Hugas was appointed Chair of the Scientific Board.

Benoit Vallet, Director General, and Patrick Dehaumont, Chair of the Board of Administrators, analyse the challenges ANSES is facing in light of its activities over the last 18 months, along with its outlook.

ANSES coordinates seven vigilance schemes aimed at identifying adverse effects caused by several types of products and foods. What are the fundamental principles underpinning this mission at the Agency? What do the new vigilance schemes for cosmetics and tattoos involve? What is the outlook for these schemes? Juliette Bloch, Director of Health Alerts and Vigilance, answers our questions.

On 1 March 2024, ANSES signed its first cooperation partnership agreement with the Croatian Agency for Agriculture and Food (HAPIH). The two agencies have areas of expertise in common relating to animal and plant health, and food safety.